Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Top Dividend Aristocrats in Pharma and Biotech
Motley Fool
Wednesday, December 29, 2010 - 10:41am
tags:
dividends, JNJ, Abbott Laboratories, Eli Lilly
Party not over for Repros shares
Bizjournals.com
Tuesday, December 28, 2010 - 4:01pm
tags:
Repros Therapeutics, Androxal, Proellex
FDA Delay Could Be Very Bad Omen For MannKind
Forbes
Tuesday, December 28, 2010 - 3:59pm
tags:
FDA, MannKind, inhaled insulin, Afrezza
Analyzing Volatility and Making a Trade in Pfizer
Yahoo/TheStreet.com
Tuesday, December 28, 2010 - 3:58pm
tags:
Pfizer, King
Takeovers Vs. R&D: What Will Drive Biotech Stocks in 2011?
Seeking Alpha
Tuesday, December 28, 2010 - 2:08pm
tags:
R&D, biotech, M&A, Cepheid, Abbott Laboratories, Bristol-Myers Squibb, Dendreon, Elan, Biogen Idec, JNJ, King, Neurocrine, Pfizer, SPDR Biotech
Biogen Idec begins selling Tysabri in India
Bizjournals.com
Tuesday, December 28, 2010 - 1:11pm
tags:
Indian, Tysabri, Biogen Idec, MS, multiple sclerosis
Cephalon’s Jet Lag Hopes For Nuvigil Are Grounded
Pharmalot
Tuesday, December 28, 2010 - 1:10pm
tags:
NUVIGIL, jet lag, Cephalon
MannKind Says FDA Will Take Another Four Weeks on Insulin Decision
WSJ Online
Tuesday, December 28, 2010 - 1:08pm
tags:
FDA, inhaled insulin, MannKind, Afrezza
BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011
Seeking Alpha
Tuesday, December 28, 2010 - 11:58am
tags:
BioSante, YM BioSciences, Lannett, EnteroMedics
Santarus climbs on FDA submission
Marketwatch
Tuesday, December 28, 2010 - 11:56am
tags:
FDA, Santarus, RHUCIN, Pharming NV, hereditary angiodema
Pfizer Call Volume Jumps, Boosted by Wager on 8.6 Percent Rally
Bloomberg
Tuesday, December 28, 2010 - 11:55am
tags:
Pfizer
Sucampo Pharmaceuticals - Upgrades & Downgrades
TheStreet.com
Tuesday, December 28, 2010 - 11:05am
tags:
Sucampo
Pfizer's Quigley Unit Bankruptcy Should Be Dismissed, U.S. Trustee Says
Bloomberg
Tuesday, December 28, 2010 - 11:05am
tags:
Pfizer, Quigley, bankruptcy
3 Catalysts That Could Push DepoMed Share Price Higher
Seeking Alpha
Tuesday, December 28, 2010 - 11:00am
tags:
Depomed, Merck, Glumetza
Six Reasons Pfizer Is a Generational Buy
Seeking Alpha
Tuesday, December 28, 2010 - 10:57am
tags:
Pfizer
J&J, AstraZeneca Halt Experimental Pain Drug Tests on Bone-Damage Concern
Bloomberg
Tuesday, December 28, 2010 - 10:56am
tags:
JNJ, AstraZeneca
[video] Sell Arena!: Against the Grain
TheStreet.com
Tuesday, December 28, 2010 - 10:47am
tags:
Arena Pharmaceuticals, obesity
[video]3 Healthcare Stocks for 2011
TheStreet.com
Tuesday, December 28, 2010 - 10:47am
tags:
Gilead Sciences, Express Scripts, CVS, Medco, Wellpoint, Medtronic
Promising Pain Drugs Put On Ice
Forbes
Tuesday, December 28, 2010 - 10:45am
tags:
painkillers, Pfizer, Regeneron, Sanofi, NGF-1
4-Star Stocks Poised to Pop: Bristol-Myers
Motley Fool
Tuesday, December 28, 2010 - 10:43am
tags:
Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.